KOCH KEVIN (President and CEO) sold 20.7% of their position (7.97K shares) of EDGEWISE THERAPEUTICS, INC. on the open market
Open‑market sale worth $106.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+17.97K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−7.97K
Price / share
$13.39
Trade value
$106.76K
% of position
Net shares
+10K
Net value
-$106.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/12/2025 | M · Option Exercise | +17.97K | — | — | 87.1% | 20.62K | 38.59K |
| Common Stock Direct | 8/12/2025 | S · Sale | −7.97K | $13.39 | $106.76K | 20.7% | 38.59K | 30.61K |
| Total | +10K | -$106.76K | ||||||
Restricted Stock Units
Common Stock
17.97K shares
Shares
−17.97K
Strike price
0.00
Held after
53.91K
Exercisable
—
Restricted Stock Units
Common Stock
87.50K shares
Shares
+87.50K
Strike price
0.00
Held after
87.50K
Exercisable
—
Stock Option (Right to Buy)
Common Stock
525K shares
Shares
+525K
Strike price
13.39
Held after
525K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock17.97K shares | 8/12/2025 | M · Option Exercise | −17.97K | 0.00 | — | 53.91K |
| Restricted Stock Units Direct | Common Stock87.50K shares | 8/12/2025 | A · Award | +87.50K | 0.00 | — | 87.50K |
| Stock Option (Right to Buy) Direct | Common Stock525K shares | 8/12/2025 | A · Award | +525K | 13.39 | — | 525K |
Common Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 26.41K | Indirect |
| Common Stock | 26.41K | Indirect |
| Common Stock | 259.55K | Indirect |
| Common Stock | 26.41K | Indirect |
| Total | 338.78K | 338.78K indirect |